IR-Med ( (IRME) ) has released a notification of late filing.
IR-Med, Inc., a company based in Rosh Pina, Israel, has announced a delay in filing its Annual Report on Form 20-F (Yearly Report) for the financial period ending December 31, 2024. The primary reason for this delay is the need for additional time to complete financial statements and related disclosures, as well as to conclude internal discussions and approvals. The company anticipates filing the report within fifteen calendar days following the prescribed due date. Importantly, IR-Med does not expect any significant changes in its financial results for the period. The notification of late filing was signed by Sharon Levkoviz, the Chief Financial Officer, indicating ongoing compliance efforts.
More about IR-Med
YTD Price Performance: 2.78%
Average Trading Volume: 1,901
Technical Sentiment Signal: Strong Buy
Current Market Cap: $34.08M
Find detailed analytics on IRME stock on TipRanks’ Stock Analysis page.